26 noviembre 2014
Researchers report that their test of an interventional X-ray guidance device approved by the US Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy for liver cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/viUHSOPO-j8/141126171430.htm
